Bioxytran, Inc.
BIXT
$0.03
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.07M | -522.20K | -282.70K | 35.40K | -1.35M |
| Total Depreciation and Amortization | 2.10K | 2.90K | 4.20K | 2.50K | 1.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.39M | 101.70K | -73.80K | -265.30K | 1.03M |
| Change in Net Operating Assets | 440.70K | 180.50K | 310.80K | 146.70K | 156.90K |
| Cash from Operations | -238.60K | -237.00K | -41.50K | -80.70K | -167.30K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9.20K | -6.20K | -1.70K | -15.20K | 0.00 |
| Cash from Investing | -9.20K | -6.20K | -1.70K | -15.20K | 0.00 |
| Total Debt Issued | -- | 20.80K | 41.20K | 94.60K | 166.50K |
| Total Debt Repaid | -40.10K | -- | -- | -- | -- |
| Issuance of Common Stock | 145.70K | 425.60K | 13.40K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 95.30K | 292.20K | -- | -- | -- |
| Cash from Financing | 201.00K | 738.60K | 54.50K | 94.60K | 166.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -46.90K | 495.40K | 11.40K | -1.20K | -800.00 |